356 related articles for article (PubMed ID: 17517710)
1. Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?
Collado MC; Meriluoto J; Salminen S
J Dairy Sci; 2007 Jun; 90(6):2710-6. PubMed ID: 17517710
[TBL] [Abstract][Full Text] [Related]
2. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.
Collado MC; Jalonen L; Meriluoto J; Salminen S
Asia Pac J Clin Nutr; 2006; 15(4):570-5. PubMed ID: 17077078
[TBL] [Abstract][Full Text] [Related]
3. Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.
Myllyluoma E; Ahonen AM; Korpela R; Vapaatalo H; Kankuri E
Clin Vaccine Immunol; 2008 Sep; 15(9):1472-82. PubMed ID: 18579692
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Campylobacter spp. and human probiotics in chicken intestinal mucus.
Ganan M; Martinez-Rodriguez AJ; Carrascosa AV; Vesterlund S; Salminen S; Satokari R
Zoonoses Public Health; 2013 Mar; 60(2):141-8. PubMed ID: 22672405
[TBL] [Abstract][Full Text] [Related]
6. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
7. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
[TBL] [Abstract][Full Text] [Related]
8. Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution.
Halttunen T; Collado MC; El-Nezami H; Meriluoto J; Salminen S
Lett Appl Microbiol; 2008 Feb; 46(2):160-5. PubMed ID: 18028332
[TBL] [Abstract][Full Text] [Related]
9. An in vitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations.
Moussavi M; Adams MC
Curr Microbiol; 2010 May; 60(5):327-35. PubMed ID: 19949794
[TBL] [Abstract][Full Text] [Related]
10. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
[TBL] [Abstract][Full Text] [Related]
11. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
Gopal PK; Prasad J; Smart J; Gill HS
Int J Food Microbiol; 2001 Aug; 67(3):207-16. PubMed ID: 11518430
[TBL] [Abstract][Full Text] [Related]
12. Adhesion of bacteria to resected human colonic tissue: quantitative analysis of bacterial adhesion and viability.
Vesterlund S; Paltta J; Karp M; Ouwehand AC
Res Microbiol; 2005 Mar; 156(2):238-44. PubMed ID: 15748990
[TBL] [Abstract][Full Text] [Related]
13. Absence of adverse events in healthy individuals using probiotics--analysis of six randomised studies by one study group.
Tapiovaara L; Lehtoranta L; Poussa T; Mäkivuokko H; Korpela R; Pitkäranta A
Benef Microbes; 2016; 7(2):161-9. PubMed ID: 26689224
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.
Hatakka K; Mutanen M; Holma R; Saxelin M; Korpela R
J Am Coll Nutr; 2008 Aug; 27(4):441-7. PubMed ID: 18978162
[TBL] [Abstract][Full Text] [Related]
15. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
Candela M; Perna F; Carnevali P; Vitali B; Ciati R; Gionchetti P; Rizzello F; Campieri M; Brigidi P
Int J Food Microbiol; 2008 Jul; 125(3):286-92. PubMed ID: 18524406
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
17. The effect of calcium ions on adhesion and competitive exclusion of Lactobacillus ssp. and E. coli O138.
Larsen N; Nissen P; Willats WG
Int J Food Microbiol; 2007 Feb; 114(1):113-9. PubMed ID: 17234293
[TBL] [Abstract][Full Text] [Related]
18. Ability of Bifidobacterium strains with acquired resistance to bile to adhere to human intestinal mucus.
Gueimonde M; Noriega L; Margolles A; de los Reyes-Gavilan CG; Salminen S
Int J Food Microbiol; 2005 Jun; 101(3):341-6. PubMed ID: 15925715
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
20. Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile--a preliminary study.
Gueimonde M; Margolles A; de los Reyes-Gavilán CG; Salminen S
Int J Food Microbiol; 2007 Jan; 113(2):228-32. PubMed ID: 16842877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
